Symbols / EVFM $0.01 -11.11% Evofem Biosciences, Inc.

Healthcare • Biotechnology • United States • PNK
EVFM Chart
About

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 1.06M
Enterprise Value 60.42M Income 274.00K Sales 20.18M
Book/sh -0.59 Cash/sh 0.00 Dividend Yield —
Payout 0.00% Employees 29 IPO —
P/E inf Forward P/E -0.01 PEG —
P/S 0.05 P/B -0.01 P/C —
EV/EBITDA 30.87 EV/Sales 2.99 Quick Ratio 0.15
Current Ratio 0.18 Debt/Eq — LT Debt/Eq —
EPS (ttm) 0.00 EPS next Y -0.55 EPS Growth —
Revenue Growth 34.60% Earnings 2024-03-27 08:00 ROA 4.08%
ROE — ROIC — Gross Margin 77.12%
Oper. Margin 34.99% Profit Margin 1.94% Shs Outstand 132.53M
Shs Float 132.53M Short Float 11.01% Short Ratio 0.19
Short Interest — 52W High 0.02 52W Low 0.01
Beta -1.29 Avg Volume 157.62K Volume 75.30K
Target Price — Recom None Prev Close $0.01
Price $0.01 Change -11.11%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.01
Latest analyst target
3. DCF / Fair value
$-0.81
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.01
Low
—
High
—
Mean
—
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
20.18
+4.23%
19.36
+6.28%
18.22
+8.20%
16.84
Operating Revenue
20.18
+4.23%
19.36
+6.28%
18.22
+8.20%
16.84
Cost Of Revenue
4.62
+20.42%
3.83
-41.12%
6.51
+47.50%
4.42
Reconciled Cost Of Revenue
4.49
+21.45%
3.70
-21.86%
4.73
+7.16%
4.42
Gross Profit
15.57
+0.24%
15.53
+32.66%
11.71
-5.76%
12.42
Operating Expense
14.13
-39.12%
23.20
-21.48%
29.55
-69.39%
96.55
Research And Development
-3.45
-286.83%
1.84
-37.22%
2.94
-88.26%
25.03
Selling General And Administration
17.07
-17.68%
20.74
-22.07%
26.61
-62.78%
71.51
Selling And Marketing Expense
9.68
+5.51%
9.18
-21.33%
11.66
-73.46%
43.95
General And Administrative Expense
7.39
-36.07%
11.56
-22.64%
14.95
-45.76%
27.56
Other Gand A
7.39
-36.07%
11.56
-22.64%
14.95
-45.76%
27.56
Total Expenses
18.74
-30.68%
27.04
-25.03%
36.06
-64.28%
100.96
Operating Income
1.44
+118.75%
-7.68
+56.99%
-17.85
+78.78%
-84.12
Total Operating Income As Reported
3.37
+143.93%
-7.68
+56.99%
-17.85
+78.78%
-84.12
EBITDA
2.06
+129.84%
-6.92
+56.93%
-16.07
+80.43%
-82.08
Normalized EBITDA
0.49
+105.92%
-8.29
+90.73%
-89.51
+2.23%
-91.55
Reconciled Depreciation
0.63
-17.20%
0.76
-57.55%
1.78
-12.95%
2.05
EBIT
1.44
+118.75%
-7.68
+56.99%
-17.85
+78.78%
-84.12
Total Unusual Items
1.57
+14.47%
1.38
-98.13%
73.44
+675.34%
9.47
Total Unusual Items Excluding Goodwill
1.57
+14.47%
1.38
-98.13%
73.44
+675.34%
9.47
Special Income Charges
1.93
+97.85%
0.98
-98.70%
75.34
+407.66%
-24.49
Other Special Charges
—
-0.98
+98.70%
-75.34
-407.66%
24.49
Restructuring And Mergern Acquisition
-1.93
0.00
—
—
Net Income
0.39
+104.41%
-8.86
-116.72%
52.98
+169.07%
-76.70
Pretax Income
0.39
+104.44%
-8.86
-116.72%
53.00
+169.14%
-76.65
Net Non Operating Interest Income Expense
0.01
-6.25%
0.02
-48.39%
0.03
-63.53%
0.09
Net Interest Income
0.01
-6.25%
0.02
-48.39%
0.03
-63.53%
0.09
Interest Income Non Operating
0.01
-6.25%
0.02
-48.39%
0.03
-63.53%
0.09
Interest Income
0.01
-6.25%
0.02
-48.39%
0.03
-63.53%
0.09
Other Income Expense
-1.06
+11.58%
-1.20
-101.69%
70.81
+858.86%
7.38
Other Non Operating Income Expenses
-2.63
-2.33%
-2.58
+2.02%
-2.63
-25.92%
-2.09
Gain On Sale Of Security
-0.36
-190.20%
0.40
+120.98%
-1.90
-105.59%
33.96
Tax Provision
0.00
0.00
-100.00%
0.02
-61.36%
0.04
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
-99.95%
0.00
Tax Effect Of Unusual Items
0.01
0.00
-100.00%
0.01
-99.63%
1.99
Net Income Including Noncontrolling Interests
0.39
+104.41%
-8.86
-116.72%
52.98
+169.07%
-76.70
Net Income From Continuing Operation Net Minority Interest
0.39
+104.41%
-8.86
-116.72%
52.98
+169.07%
-76.70
Net Income From Continuing And Discontinued Operation
0.39
+104.41%
-8.86
-116.72%
52.98
+169.07%
-76.70
Net Income Continuous Operations
0.39
+104.41%
-8.86
-116.72%
52.98
+169.07%
-76.70
Normalized Income
-1.17
+88.52%
-10.23
+49.96%
-20.45
+75.70%
-84.18
Net Income Common Stockholders
0.27
+103.06%
-8.96
-117.93%
49.99
+164.08%
-78.01
Diluted EPS
—
-0.12
-340.00%
0.05
+100.03%
-167.50
Basic EPS
—
-0.12
-101.16%
10.36
+106.19%
-167.50
Basic Average Shares
—
75.20
+1457.89%
4.83
+935.82%
0.47
Diluted Average Shares
—
75.20
-92.36%
984.04
+211074.33%
0.47
Diluted NI Availto Com Stockholders
0.27
+103.06%
-8.96
-117.93%
49.99
+164.08%
-78.01
Amortization
0.50
-19.39%
0.62
0.00
—
Amortization Of Intangibles Income Statement
0.50
-19.39%
0.62
0.00
—
Depreciation Amortization Depletion Income Statement
0.50
-19.39%
0.62
0.00
—
Depreciation And Amortization In Income Statement
0.50
-19.39%
0.62
0.00
—
Preferred Stock Dividends
0.12
+11.43%
0.10
-96.48%
2.98
+126.75%
1.32
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
20.27
-14.78%
23.79
+125.40%
10.55
-58.06%
25.16
Current Assets
15.28
+12.31%
13.61
+47.76%
9.21
-27.47%
12.70
Cash Cash Equivalents And Short Term Investments
—
0.00
0.00
-100.00%
2.77
Cash And Cash Equivalents
—
0.00
0.00
-100.00%
2.77
Receivables
12.86
+30.77%
9.83
+71.35%
5.74
+409.59%
1.13
Accounts Receivable
12.48
+26.93%
9.83
+71.35%
5.74
+409.59%
1.13
Other Receivables
0.38
—
—
—
Inventory
1.13
-28.41%
1.58
-7.07%
1.70
-68.45%
5.38
Raw Materials
0.21
-41.14%
0.35
-32.69%
0.52
—
Work In Process
0.30
-69.35%
0.98
+154.40%
0.39
—
Finished Goods
0.62
+153.88%
0.24
-69.03%
0.79
—
Prepaid Assets
0.13
+3.15%
0.13
+67.11%
0.08
-95.75%
1.79
Restricted Cash
0.58
-22.00%
0.74
+27.76%
0.58
-51.95%
1.21
Other Current Assets
0.59
-55.78%
1.33
+19.03%
1.12
-49.55%
2.22
Total Non Current Assets
4.99
-50.98%
10.18
+657.44%
1.34
-89.22%
12.46
Net PPE
0.60
+9.69%
0.55
-58.21%
1.31
-84.32%
8.35
Gross PPE
0.72
-42.63%
1.25
-49.98%
2.50
-78.37%
11.54
Accumulated Depreciation
-0.12
+83.45%
-0.70
+40.89%
-1.19
+62.81%
-3.19
Properties
—
—
0.00
0.00
Machinery Furniture Equipment
0.04
-75.17%
0.14
-77.59%
0.65
-57.43%
1.52
Construction In Progress
0.40
-6.29%
0.43
-62.89%
1.16
-26.28%
1.57
Other Properties
0.28
-58.75%
0.67
-2.60%
0.69
-86.32%
5.06
Leases
—
—
0.00
-100.00%
3.39
Goodwill And Other Intangible Assets
4.35
-54.69%
9.60
0.00
—
Other Intangible Assets
4.35
-54.69%
9.60
—
—
Non Current Prepaid Assets
—
—
0.00
-100.00%
1.72
Other Non Current Assets
0.04
+16.67%
0.04
+2.86%
0.04
-98.54%
2.40
Total Liabilities Net Minority Interest
94.61
-0.46%
95.05
+23.33%
77.06
-20.52%
96.96
Current Liabilities
84.82
+5.43%
80.45
+11.02%
72.46
-22.77%
93.83
Payables And Accrued Expenses
13.79
-34.87%
21.18
-0.33%
21.25
+11.19%
19.11
Payables
13.15
-18.67%
16.17
-4.98%
17.02
+13.59%
14.98
Accounts Payable
13.15
-18.67%
16.17
-4.98%
17.02
+13.59%
14.98
Current Accrued Expenses
0.64
-87.23%
5.00
+18.38%
4.23
+2.50%
4.12
Pensionand Other Post Retirement Benefit Plans Current
3.24
-18.98%
4.00
+53.28%
2.61
+19.95%
2.17
Current Debt And Capital Lease Obligation
54.49
+18.57%
45.96
+5.98%
43.37
-36.22%
68.00
Current Debt
54.37
+18.50%
45.88
+6.03%
43.27
-34.13%
65.68
Other Current Borrowings
54.37
+18.50%
45.88
+6.03%
43.27
-34.13%
65.68
Current Capital Lease Obligation
0.13
+56.10%
0.08
-15.46%
0.10
-95.80%
2.31
Current Deferred Liabilities
0.40
0.00
—
—
Current Deferred Revenue
0.40
0.00
—
—
Other Current Liabilities
12.89
+38.43%
9.31
+77.66%
5.24
+15.16%
4.55
Total Non Current Liabilities Net Minority Interest
9.79
-32.94%
14.60
+217.28%
4.60
+46.86%
3.13
Long Term Debt And Capital Lease Obligation
0.05
+671.43%
0.01
-12.50%
0.01
-99.74%
3.13
Long Term Capital Lease Obligation
0.05
+671.43%
0.01
-12.50%
0.01
-99.74%
3.13
Other Non Current Liabilities
4.84
-50.69%
9.81
—
—
Preferred Securities Outside Stock Equity
4.90
+2.45%
4.78
+4.11%
4.59
0.00
Stockholders Equity
-74.34
-4.32%
-71.26
-7.14%
-66.51
+7.37%
-71.80
Common Stock Equity
-74.34
-4.32%
-71.26
-7.14%
-66.51
+7.37%
-71.80
Capital Stock
0.01
+18.18%
0.01
+450.00%
0.00
0.00
Common Stock
0.01
+18.18%
0.01
+450.00%
0.00
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
126.69
+11.76%
113.36
+466.56%
20.01
+1931.69%
0.98
Ordinary Shares Number
126.69
+11.76%
113.36
+466.56%
20.01
+1931.69%
0.98
Additional Paid In Capital
831.86
+0.34%
829.03
+0.73%
823.04
+0.69%
817.37
Retained Earnings
-897.39
+0.03%
-897.66
-1.01%
-888.70
+5.33%
-938.69
Gains Losses Not Affecting Retained Earnings
-8.82
-235.29%
-2.63
-209.78%
-0.85
-101.71%
49.53
Other Equity Adjustments
-8.82
-235.29%
-2.63
-209.78%
-0.85
-101.71%
49.53
Total Equity Gross Minority Interest
-74.34
-4.32%
-71.26
-7.14%
-66.51
+7.37%
-71.80
Total Capitalization
-74.34
-4.32%
-71.26
-7.14%
-66.51
+7.37%
-71.80
Working Capital
-69.54
-4.04%
-66.84
-5.67%
-63.25
+22.04%
-81.13
Invested Capital
-19.97
+21.31%
-25.38
-9.19%
-23.24
-280.02%
-6.12
Total Debt
54.55
+18.67%
45.97
+5.98%
43.37
-39.02%
71.13
Net Debt
54.37
+18.50%
45.88
+6.03%
43.27
-31.23%
62.91
Capital Lease Obligations
0.18
+104.49%
0.09
-15.24%
0.10
-98.07%
5.44
Net Tangible Assets
-78.68
+2.68%
-80.85
-21.57%
-66.51
+7.37%
-71.80
Tangible Book Value
-78.68
+2.68%
-80.85
-21.57%
-66.51
+7.37%
-71.80
Notes Receivable
—
—
—
—
Preferred Stock Equity
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-1.99
+48.73%
-3.88
+56.68%
-8.97
+87.26%
-70.41
Cash Flow From Continuing Operating Activities
-1.99
+48.73%
-3.88
+56.68%
-8.97
+87.26%
-70.41
Net Income From Continuing Operations
0.39
+104.41%
-8.86
-116.72%
52.98
+169.07%
-76.70
Depreciation Amortization Depletion
0.63
-17.20%
0.76
-57.55%
1.78
-12.95%
2.05
Depreciation
0.13
-7.30%
0.14
-92.31%
1.78
-12.95%
2.05
Amortization Cash Flow
0.50
-19.39%
0.62
0.00
—
Depreciation And Amortization
0.63
-17.20%
0.76
-57.55%
1.78
-12.95%
2.05
Amortization Of Intangibles
0.50
-19.39%
0.62
0.00
—
Other Non Cash Items
-5.15
-267.01%
3.08
+70.90%
1.80
-44.37%
3.24
Stock Based Compensation
0.17
-80.40%
0.85
-28.76%
1.19
-64.11%
3.31
Provisionand Write Offof Assets
—
—
1.58
+625.33%
-0.30
Asset Impairment Charge
1.01
+1506.35%
0.06
-96.00%
1.58
—
Operating Gains Losses
0.02
-99.35%
3.06
+104.49%
-68.15
-168.89%
98.92
Gain Loss On Investment Securities
—
3.30
-51.30%
6.78
-90.72%
72.99
Unrealized Gain Loss On Investment Securities
0.36
+109.71%
-3.70
+24.21%
-4.88
+95.44%
-106.95
Net Foreign Currency Exchange Gain Loss
—
—
0.00
-100.00%
0.51
Gain Loss On Sale Of PPE
0.02
-97.28%
0.73
-70.77%
2.51
+171.17%
0.93
Change In Working Capital
0.58
-32.76%
0.87
-81.66%
4.73
-21.44%
6.02
Change In Receivables
-2.65
+35.32%
-4.09
+11.23%
-4.61
-186.64%
5.32
Changes In Account Receivables
-2.65
+35.32%
-4.09
+11.23%
-4.61
-186.64%
5.32
Change In Inventory
-0.26
-556.14%
0.06
-97.29%
2.11
+34.48%
1.57
Change In Prepaid Assets
0.36
+234.34%
-0.27
-107.24%
3.66
+41.19%
2.59
Change In Payables And Accrued Expense
3.74
-29.04%
5.28
+4.43%
5.05
+339.38%
-2.11
Change In Accrued Expense
3.56
-42.43%
6.18
+543.60%
0.96
+114.60%
-6.58
Change In Payable
0.18
+120.00%
-0.91
-122.25%
4.09
-8.58%
4.47
Change In Account Payable
0.18
+120.00%
-0.91
-122.25%
4.09
-8.58%
4.47
Change In Other Working Capital
—
—
0.43
+117.51%
-2.48
Change In Other Current Liabilities
-0.61
-473.58%
-0.11
+92.83%
-1.48
-9.16%
-1.35
Investing Cash Flow
-0.06
+89.10%
-0.57
-14125.00%
-0.00
+98.83%
-0.34
Cash Flow From Continuing Investing Activities
-0.06
+89.10%
-0.57
-14125.00%
-0.00
+98.83%
-0.34
Net PPE Purchase And Sale
-0.01
+64.29%
-0.01
-250.00%
-0.00
+98.83%
-0.34
Purchase Of PPE
-0.01
+64.29%
-0.01
-250.00%
-0.00
+98.83%
-0.34
Capital Expenditure
-0.01
+64.29%
-0.01
-250.00%
-0.00
+98.83%
-0.34
Net Investment Purchase And Sale
—
—
—
0.00
Sale Of Investment
—
—
—
0.00
Net Business Purchase And Sale
—
—
—
0.00
Net Other Investing Changes
-0.06
+89.73%
-0.56
—
—
Financing Cash Flow
1.89
-59.02%
4.62
-3.37%
4.78
-92.29%
61.94
Cash Flow From Continuing Financing Activities
1.89
-59.02%
4.62
-3.37%
4.78
-92.29%
61.94
Net Issuance Payments Of Debt
1.90
+594.29%
-0.39
-108.58%
4.49
-20.01%
5.61
Issuance Of Debt
2.81
+607.30%
0.40
-92.96%
5.64
-50.96%
11.50
Repayment Of Debt
-0.91
-15.73%
-0.78
+32.24%
-1.15
+80.41%
-5.89
Long Term Debt Issuance
2.42
—
5.64
-50.96%
11.50
Long Term Debt Payments
—
—
-1.15
+80.41%
-5.89
Net Long Term Debt Issuance
2.42
—
4.49
-20.01%
5.61
Short Term Debt Issuance
0.38
-3.53%
0.40
-92.96%
5.64
—
Short Term Debt Payments
-0.91
-15.73%
-0.78
+32.24%
-1.15
—
Net Short Term Debt Issuance
-0.52
-35.58%
-0.39
-108.58%
4.49
—
Net Common Stock Issuance
0.00
-100.00%
5.00
0.00
-100.00%
32.30
Common Stock Payments
—
—
0.00
+100.00%
-0.02
Repurchase Of Capital Stock
—
—
0.00
+100.00%
-0.02
Proceeds From Stock Option Exercised
—
0.00
-100.00%
0.29
-98.85%
25.23
Net Other Financing Charges
-0.01
—
—
-1.20
Changes In Cash
-0.16
-201.24%
0.16
+103.84%
-4.20
+52.38%
-8.81
Beginning Cash Position
0.74
+27.76%
0.58
-87.86%
4.78
-64.85%
13.59
End Cash Position
0.58
-22.00%
0.74
+27.76%
0.58
-87.86%
4.78
Free Cash Flow
-2.00
+48.78%
-3.90
+56.54%
-8.97
+87.32%
-70.75
Interest Paid Supplemental Data
0.02
-89.94%
0.16
-52.96%
0.34
-51.58%
0.70
Income Tax Paid Supplemental Data
0.00
-75.00%
0.01
+100.00%
0.00
-84.62%
0.03
Common Stock Issuance
0.00
-100.00%
5.00
0.00
-100.00%
32.32
Issuance Of Capital Stock
0.00
-100.00%
5.00
0.00
-100.00%
32.32
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
Sale Of Business
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category